Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antianginal therapy '95]

M Stejfa1

  • 1I. interní klinika FN U sv. Anny LF MU, Brno.

Vnitrni Lekarstvi
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

This review outlines current antianginal treatment strategies, focusing on therapeutic algorithms for cardiac ischemia and angina pectoris. It details medication options and their timing relative to revascularization procedures.

Related Concept Videos

Coagulation01:06

Coagulation

1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation01:09

Coagulation

8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Internal medicine and cardiology, internists and cardiologists].

Vnitrni lekarstvi·2011
Same author

[A reflection on internal medicine].

Vnitrni lekarstvi·2009
Same author

[Physical training in patients with chornic heart failure: haemodynamics, effects].

Vnitrni lekarstvi·2005
Same author

[Pathways in the development of electrocardiography].

Vnitrni lekarstvi·2003
Same author

[Lipids and acute coronary syndromes].

Vnitrni lekarstvi·2001
Same author

Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1998
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Review of contemporary antianginal treatment options.
  • Discussion of pathophysiological and morphological aspects of cardiac ischemia and angina pectoris.

Purpose:

  • To provide evidence-based algorithms for therapeutic decisions in managing angina pectoris.
  • To detail the role of both pharmacotherapy and revascularization in treatment strategies.

Summary:

  • The review covers nitrates, beta-blockers, calcium channel inhibitors, and antithrombotics, including their mechanisms, indications, contraindications, side effects, and dosages.
  • It emphasizes the integration of medication with invasive procedures like revascularization, offering guidance for timing and application.
  • Angiotensin-converting enzyme inhibitors are also mentioned as part of the therapeutic landscape.

Related Experiment Videos

Impact:

  • Aims to guide clinicians in optimizing treatment strategies for patients with angina pectoris.
  • Highlights the evolving nature of antianginal treatment based on advancing medical knowledge.